Articles By Keyword

. "Diseased region detection of longitudinal knee magnetic resonance imaging data.." IEEE Trans Med Imaging. 2015;34(9):1914-27. Pub Med
. "Diseased region detection of longitudinal knee MRI data.." Inf Process Med Imaging. 2013;23():632-43. Pub Med
. "A framework for understanding cancer comparative effectiveness research data needs.." J Clin Epidemiol. 2012;65(11):1150-8. Pub Med
. "Prospects and challenges for clinical decision support in the era of big data.." JCO Clin Cancer Inform. 2018;2():. Pub Med
. "Optimal two-stage dynamic treatment regimes from a classification perspective with censored survival data.." Biometrics. 2018;74(4):1180-1192. Pub Med
. "Discussion of combining biomarkers to optimize patient treatment recommendations.." Biometrics. 2014;70(3):713-6. Pub Med
. "Bayesian design of superiority clinical trials for recurrent events data with applications to bleeding and transfusion events in myelodyplastic syndrome.." Biometrics. 2014;70(4):1003-13. Pub Med
. "Additive mixed effect model for clustered failure time data.." Biometrics. 2011;67(4):1340-51. Pub Med
. "Assessing the causal effect of organ transplantation on the distribution of residual lifetime.." Biometrics. 2013;69(4):820-9. Pub Med
. "Efficient semiparametric estimation of short-term and long-term hazard ratios with right-censored data.." Biometrics. 2013;69(4):840-9. Pub Med
. "Analysis of multiple survival events in generalized case-cohort designs.." Biometrics. 2018;74(4):1250-1260. Pub Med
. "Bayesian path specific frailty models for multi-state survival data with applications.." Biometrics. 2015;71(3):760-71. Pub Med
. "Discussion of "Combining biomarkers to optimize patient treatment recommendation".." Biometrics. 2014;70(3):707-10. Pub Med
. "Doubly-robust estimators of treatment-specific survival distributions in observational studies with stratified sampling.." Biometrics. 2013;69(4):830-9. Pub Med
. "Response to reader reaction.." Biometrics. 2015;71(1):267-273. Pub Med
. "A robust method for estimating optimal treatment regimes.." Biometrics. 2012;68(4):1010-8. Pub Med
. "Accelerated intensity frailty model for recurrent events data.." Biometrics. 2014;70(3):579-87. Pub Med
. "Reinforcement learning strategies for clinical trials in nonsmall cell lung cancer.." Biometrics. 2011;67(4):1422-33. Pub Med
. "Sensitivity analysis for missing outcomes in time-to-event data with covariate adjustment.." J Biopharm Stat. 2016;26(2):269-79. Pub Med
. "Accelerated failure time model for data from outcome-dependent sampling.." Lifetime Data Anal. 2021;27(1):15-37. Pub Med
. "Secondary outcome analysis for data from an outcome-dependent sampling design.." Stat Med. 2018;37(15):2321-2337. Pub Med
. "Augmented outcome-weighted learning for estimating optimal dynamic treatment regimens.." Stat Med. 2018;37(26):3776-3788. Pub Med
. "Bivariate random effects models for meta-analysis of comparative studies with binary outcomes: methods for the absolute risk difference and relative risk.." Stat Methods Med Res. 2012;21(6):621-33. Pub Med
. "A penalized likelihood approach for investigating gene-drug interactions in pharmacogenetic studies.." Biometrics. 2015;71(2):529-37. Pub Med
. "Assessing the dependence of sensitivity and specificity on prevalence in meta-analysis.." Biostatistics. 2011;12(4):710-22. Pub Med
. "Predictive blood-based biomarkers in patients with epithelial ovarian cancer treated with carboplatin and paclitaxel with or without bevacizumab: Results from GOG-0218.." Clin Cancer Res. 2020;26(6):1288-1296. Pub Med
. "Translational studies of phenotypic probes for the mononuclear phagocyte system and liposomal pharmacology.." J Pharmacol Exp Ther. 2013;347(3):599-606. Pub Med
. "A simple and robust method for multivariate meta-analysis of diagnostic test accuracy.." Stat Med. 2017;36(1):105-121. Pub Med
. "Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer.." J Natl Cancer Inst. 2012;104(3):211-27. Pub Med
. "Intergenerational response to the endocrine disruptor vinclozolin is influenced by maternal genotype and crossing scheme.." Reprod Toxicol. 2018;78():9-19. Pub Med
. "Predictive blood-based biomarkers in patients with epithelial ovarian cancer treated with carboplatin and paclitaxel with or without bevacizumab: Results from GOG-0218.." Clin Cancer Res. 2020;26(6):1288-1296. Pub Med
. "A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101.." Clin Cancer Res. 2012;18(18):5099-109. Pub Med
. "Genomewide meta-analysis validates a role for S1PR1 in microtubule targeting agent-induced sensory peripheral neuropathy.." Clin Pharmacol Ther. 2020;108(3):625-634. Pub Med
. "Pharmacogenetics, enzyme probes and therapeutic drug monitoring as potential tools for individualizing taxane therapy.." Pharmacogenomics. 2013;14(5):555-74. Pub Med
. "Optimizing delivery of a behavioral pain intervention in cancer patients using a sequential multiple assignment randomized trial SMART.." Contemp Clin Trials. 2017;57():51-57. Pub Med
. "Optimizing delivery of a behavioral pain intervention in cancer patients using a sequential multiple assignment randomized trial SMART.." Contemp Clin Trials. 2017;57():51-57. Pub Med
. "Purity independent subtyping of tumors (PurIST), a clinically robust, single-sample classifier for tumor subtyping in pancreatic cancer.." Clin Cancer Res. 2020;26(1):82-92. Pub Med
. "Biomarker threshold adaptive designs for survival endpoints.." J Biopharm Stat. 2018;28(6):1038-1054. Pub Med
. "Bayesian gamma frailty models for survival data with semi-competing risks and treatment switching.." Lifetime Data Anal. 2014;20(1):76-105. Pub Med
. "A unification of models for meta-analysis of diagnostic accuracy studies without a gold standard.." Biometrics. 2015;71(2):538-47. Pub Med
. "Time course and prognostic value of serum GFAP, pNFH, and S100β concentrations in dogs with complete spinal cord injury because of intervertebral disc extrusion.." J Vet Intern Med. 2019;33(2):726-734. Pub Med
. "Estimating personalized diagnostic rules depending on individualized characteristics.." Stat Med. 2017;36(7):1099-1117. Pub Med
. "A global logrank test for adaptive treatment strategies based on observational studies.." Stat Med. 2014;33(5):760-71. Pub Med
. "Sequential multiple assignment randomization trials with enrichment design.." Biometrics. 2017;73(2):378-390. Pub Med
. "Bayesian modeling and inference for clinical trials with partial retrieved data following dropout.." Stat Med. 2013;32(24):4180-95. Pub Med
. "A new Bayesian joint model for longitudinal count data with many zeros, intermittent missingness, and dropout with applications to HIV prevention trials.." Stat Med. 2019;38(30):5565-5586. Pub Med
. "Kappa statistic for clustered dichotomous responses from physicians and patients.." Stat Med. 2013;32(21):3700-19. Pub Med
. "Incorporating patient preferences into estimation of optimal individualized treatment rules.." Biometrics. 2018;74(1):18-26. Pub Med
. "Efficient methods for signal detection from correlated adverse events in clinical trials.." Biometrics. 2019;75(3):1000-1008. Pub Med
. "Medical records-based postmarketing safety evaluation of rare events with uncertain status.." J Biopharm Stat. 2013;23(1):201-12. Pub Med